Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. Otsuka is a healthcare company driven by our purpose and defined by our beliefs. At Otsuka, we hold a deep respect for the value of every mind. residents only.

We believe that the human mind is infinitely valuable, fostering imagination, intelligence, perception, and so much more. By recognizing this value, we have the power to change the trajectory of people’s lives. This is why we will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention. Through products, programs, policies, and advocacy, Otsuka-people will defy any limitation that stands in their way until every mind is valued. This commitment extends to those who care for people living with mental illnesses and other brain conditions. We are dedicated to caring for those who care for our patients—standing with them, the way they stand with their loved ones—and offering the tools they need for the health of others and themselves

----
There are two Otsuka pharmaceutical industry companies in the U.S.:

Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis

Learn more at www.otsuka-us.com

----
Community Guidelines:

Welcome to the Otsuka page. We're excited to have you be part of our Facebook community, and look forward to discussing a variety of topics. However, we'd like to remind you that healthcare is a regulated industry and, as such, we cannot engage in discussions about our products – or the products of other companies. With this in mind, we may not be able to respond to or comments that:
Mention products
Include profanity, defamatory or abusive comments
Offer health or medical advice
Are spam or are soliciting business
Violate Facebook's platform rules

Please keep in mind that this page is intended for U.S. Also, please note that Facebook accounts that the Otsuka handle follows, or are followed by, are not an indication of an endorsement by Otsuka feeds or the content they produce. With this in mind, comments made on third party feeds that the Otsuka handle follows do not necessarily represent the opinion of Otsuka America Pharmaceutical, Inc., or Otsuka Pharmaceutic Development & Commercialization, Inc. Medical Side Effects or Adverse Events
If you believe that you have experienced any medical side effects or reactions from an Otsuka product, you should consult your physician, pharmacist or other healthcare professional immediately. If you wish to report an adverse event associated with any of our products, please call us at 1-800-438-9927. The FDA also has a website where you can report side effects of prescription drugs at www.fda.gov/medwatch, or call 1-800-FDA-1088.

We are feeling energized after our time spent with the ADHD Community at the 2026 American Professional Society of ADHD ...
01/30/2026

We are feeling energized after our time spent with the ADHD Community at the 2026 American Professional Society of ADHD and Related Disorders (APSARD) earlier this month.

Thank you to everyone who stopped by our Disease State Education Booth to learn more about our focus on patients with ADHD.

At Otsuka, we will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention.

Discover our commitment at www.otsuka-us.com/CNS
Otsuka is a proud sponsor of APSARD.

Today, we are pleased to announce that the U.S. U.S. Food and Drug Administration (FDA) has accepted for priority review...
01/27/2026

Today, we are pleased to announce that the U.S. U.S. Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for centanafadine, an investigational, once-daily extended release capsule and the first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.

Learn more: https://bit.ly/4t2JaSS

At Otsuka, we will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention.

Caregivers often feel guilty for needing rest, but it’s okay to pause, recharge, and care for yourself, too.    At Otsuk...
01/20/2026

Caregivers often feel guilty for needing rest, but it’s okay to pause, recharge, and care for yourself, too.

At Otsuka, we’re leading a change in how caregivers are recognized, supported, and cared for.

That’s why we’ve created a new resource designed to support the way you nurture your own mental health—because your well-being matters, too. 💕

Share now: https://bit.ly/4q811px
------
Otsuka knows that within the mind of every caregiver, there is an immeasurable love and an unimaginable strength. To bring to light their unwavering dedication, Otsuka is committed to valuing the minds of caregivers everywhere—offering resources that may support their care for themselves and others.

This week, at the 44th Annual J.P. Morgan Healthcare Conference, healthcare leaders from around the world are coming tog...
01/14/2026

This week, at the 44th Annual J.P. Morgan Healthcare Conference, healthcare leaders from around the world are coming together to exchange insights, foster collaboration, and drive meaningful impact across the global healthcare ecosystem.​

During a happy hour event hosted in collaboration with Endpoints News on January 13, Tarek Rabah, President and Chief Executive Officer at Otsuka, shared opening remarks discussing Otsuka's vision on how we plan to accelerate access to breakthrough treatments for patients we collectively serve​

Read key takeaways from his remarks.

01/13/2026

We are thrilled to attend 2026 American Professional Society of ADHD and Related Disorders (APSARD) and look forward to meeting ADHD experts, professionals, leaders and advocates from across the world.

For those registered to attend, we invite you to join us at our Disease State Education Booth in the Seaport Ballroom throughout the conference to learn more about our focus on patients with ADHD.

Discover our commitment at www.otsuka-us.com/CNS

Otsuka is a proud sponsor of APSARD. Only registered participants of the APSARD meeting are eligible to attend as determined by the event organizer, APSARD. Otsuka has no control over registration, or the fees associated.

01/09/2026

In 2024, approximately 1 in 20 adults in the U.S. had a serious mental illness in the past year (SAMHSA).

For National Mental Wellness Month, check in with your loved ones and offer them the support and resources they may need and advocate for better health for all.

We hold a deep respect for the value of every mind and will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health, warranting early, equitable, and accessible intervention for patients and caregivers everywhere.

Discover our commitment to health for every mind: https://bit.ly/3Z3eyTn

Family caregivers give so much of themselves every day. 💛At Otsuka, we’re leading a change in how caregivers are recogni...
01/08/2026

Family caregivers give so much of themselves every day. 💛

At Otsuka, we’re leading a change in how caregivers are recognized, supported, and cared for.

That’s why we’ve created a new resource designed to support the way you nurture your own mental health—because your well-being matters, too. 💕
Share now: https://bit.ly/4q811px
------
Otsuka knows that within the mind of every caregiver, there is an immeasurable love and an unimaginable strength. To bring to light their unwavering dedication, Otsuka is committed to valuing the minds of caregivers everywhere—offering resources that may support their care for themselves and others.

“Caregivers are doing the equivalent of a second full-time job while navigating complex systems,” says John McHugh, PhD,...
12/17/2025

“Caregivers are doing the equivalent of a second full-time job while navigating complex systems,” says John McHugh, PhD, a Columbia health-policy researcher and lead investigator on the report. “We have to meet their mental health needs with the same urgency and compassion as their loved ones’ physical needs.”

Otsuka knows that within the mind of every caregiver, there is an immeasurable love and an unimaginable strength. To bring to light their unwavering dedication, Otsuka is committed to valuing the minds of caregivers everywhere—offering resources that may support their care for themselves and others.

Read the full Women's Health Magazine article now: https://bit.ly/3YuzmTA

Otsuka is the financial sponsor of The America's Unseen Workforce Report conducted by John McHugh, PhD, Columbia health-policy researcher and lead investigator on the report.

Our core values of perseverance, unconventional thinking and humility position us to lead in the development of the tran...
12/16/2025

Our core values of perseverance, unconventional thinking and humility position us to lead in the development of the transformative potential of these therapies in mental healthcare. ​

Learn more about our commitment: www.otsuka-us.com/CNS

12/10/2025

The caregiver community is vast and beautiful, and the work of caregivers deserves to be seen and valued. 💜💜💜

At Otsuka, we’re working to lead an industry-wide shift in the ways caregivers are valued and supported. We are dedicated to caring for caregivers—standing with them, the way they stand with their loved ones— and offering resources that may support their care for themselves and others.

Learn more about our Caregiver Commitment and uncover the depths of compassion through the firsthand experiences of caregivers: https://bit.ly/45tW6YO


May 2025 01US22EUC0159

12/05/2025

Rates of anxiety, depression, and other mental health issues are high among family caregivers, with nearly half of family caregivers (47%) reporting these challenges in the past year. This urgent reality highlights why we must treat the mental health of family caregivers with the same urgency as physical health.

At Otsuka, we’re working to lead an industry-wide shift in the ways caregivers are valued and supported. We are dedicated to caring for caregivers—standing with them, the way they stand with their loved ones.

Read more on Vice President, Corporate Affairs, Otsuka America Pharmaceutical, Inc., Debra Barrett’s perspective at Forbes: https://bit.ly/4nE87RE

12/04/2025

At Otsuka, we are using industry-leading science and meticulous, thoughtful drug development to optimize the therapeutic potential of our family of novel serotonergic agonists. ​

Learn more about our commitment: www.otsuka-us.com/CNS

Address

508 Carnegie Center
Princeton, NJ
08540

Alerts

Be the first to know and let us send you an email when Otsuka America Pharmaceutical, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram